Parvovirus-B19-associated complications in renal transplant recipients
- 1 October 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Nephrology
- Vol. 3 (10), 540-550
- https://doi.org/10.1038/ncpneph0609
Abstract
Parvovirus B19 is a common human pathogen, causing erythema infectiosum in children, hydrops fetalis in pregnant women, and transient aplastic crisis in patients with chronic hemolytic anemia. Immunosuppressed patients can fail to mount an effective immune response to B19, resulting in prolonged or persistent viremia. Renal transplant recipients can develop symptomatic B19 infections as a result of primary infection acquired via the usual respiratory route or via the transplanted organ, or because of reactivation of latent or persistent viral infection. The most common manifestations of B19 infection in immunosuppressed patients are pure red cell aplasia and other cytopenias. Thus, this diagnosis should be considered in transplant recipients with unexplained anemia and reticulocytopenia or pancytopenia. Collapsing glomerulopathy and thrombotic microangiopathy have been reported in association with B19 infection in renal transplant recipients, but a causal relationship has not been definitively established. Prompt diagnosis of B19 infection in the renal transplant recipient requires a high index of suspicion and careful selection of diagnostic tests, which include serologies and polymerase chain reaction. Most patients benefit from intravenous immunoglobulin therapy and/or alteration or reduction of immunosuppressive therapy. Conservative therapy might be sufficient in some cases.Keywords
This publication has 99 references indexed in Scilit:
- Biological and Immunological Relations among Human Parvovirus B19 Genotypes 1 to 3Journal of Virology, 2007
- Tracking of Peptide-Specific CD4+T-Cell Responses after an Acute Resolving Viral Infection: a Study of Parvovirus B19Journal of Virology, 2006
- Molecular and Functional Analyses of a Human Parvovirus B19 Infectious Clone Demonstrates Essential Roles for NS1, VP1, and the 11-Kilodalton Protein in Virus Replication and InfectivityJournal of Virology, 2006
- Aberrant cellular immune responses in humans infected persistently with parvovirus B19Journal of Medical Virology, 2005
- Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 InfectionPLoS Medicine, 2005
- Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patientPediatric Nephrology, 2005
- Identification of an Immunodominant Peptide in the Parvovirus B19 VP1 Unique Region Able to Elicit a Long-Lasting Immune Response in HumansViral Immunology, 2001
- Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipientNephrology Dialysis Transplantation, 1996
- Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipientEuropean Journal of Haematology, 1995
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989